Who has invested in Cerecin?

Wilmar, Inventages are named among the investors backing Cerecin.

Cerecin Funding: $50M Raised, Series B (2018)

Cerecin funding overview

Cerecin is based in Denver. Cerecin has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2018. The round record for Cerecin runs through 2018; nothing later has been disclosed. Investors on record include Wilmar, Inventages. 2 distinct backers are named across the disclosed rounds.

Cerecin at a glance

Total raised: $50M
Latest round: Series B
Latest round date: October 2018
Headquarters: Denver
Notable investors: Wilmar, Inventages

Frequently asked about Cerecin funding

How much has Cerecin raised?: Cerecin has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Cerecin?: Wilmar, Inventages are named among the investors backing Cerecin.
What was the latest Cerecin funding round?: The most recent disclosed round is a Series B, announced in October 2018.
Where is Cerecin based?: Cerecin is based in Denver.
When did Cerecin last raise?: The last disclosed Cerecin round closed in October 2018 at Series B.

Totals shown for Cerecin aggregate every disclosed round on file. To see how that compares, browse the companies in Denver and the investors behind them below.

Cerecin Funding: $50M Raised, Series B (2018)

Cerecin funding overview

Cerecin at a glance

Frequently asked about Cerecin funding

Companies related to Cerecin (18)

Browse related funding lists (3)